Learn More
Medchemexpress LLC Lapaquistat acetate | 189060-13-7 | 99.1% | 645.14 | 1 MG

Supplier: Medchemexpress LLC 1MGHY16274
Lapaquistat acetate (TAK-475) is a squalene synthase inhibitor that blocks the conversion of farnesyl diphosphate (FPP) to squalene in the cholesterol biosynthesis pathway. It is effective at lowering low-density lipoprotein cholesterol and is used for hypercholesterolemia and mevalonate kinase deficiency (MKD) research.
- Squalene synthase inhibitor
- Blocks conversion of farnesyl diphosphate (FPP) to squalene
- Lowers low-density lipoprotein cholesterol
- Used for hypercholesterolemia research
- Used for mevalonate kinase deficiency (MKD) research
- Solid appearance, white to off-white color
- Powder storage: -20°C for 3 years
- In solvent storage: -80°C for 6 months, -20°C for 1 month
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.